Contact
Please use this form to send email to PR contact of this press release:
FDA approves daratumumab and hyaluronidase-fihj for high-risk smoldering multiple myeloma
TO:
Please use this form to send email to PR contact of this press release:
FDA approves daratumumab and hyaluronidase-fihj for high-risk smoldering multiple myeloma
TO: